Artículos de revistas sobre el tema "INTERFERON SIGNATURE"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "INTERFERON SIGNATURE".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Visan, Ioana. "The interferon signature". Nature Immunology 18, n.º 2 (febrero de 2017): 151. http://dx.doi.org/10.1038/ni.3670.
Texto completoSuspitsin, E. N., R. K. Raupov, E. M. Kuchinskaya y M. M. Kostik. "Analysis of interferon type I signature for differential diagnosis of diseases of the immune system ( review of literature)". Russian Clinical Laboratory Diagnostics 66, n.º 5 (23 de mayo de 2021): 279–84. http://dx.doi.org/10.51620/0869-2084-2021-66-5-279-284.
Texto completoSmith, Michael Alexander, Chia-Chien Chiang, Dominic Sinibaldi, Kamelia Zerrouki, Zerai Manna, Wendy I. White, Mariana J. Kaplan et al. "Using the Circulating Proteome to Assess Type I Interferon Activity in Systemic Lupus Erythematosus". Journal of Immunology 198, n.º 1_Supplement (1 de mayo de 2017): 210.1. http://dx.doi.org/10.4049/jimmunol.198.supp.210.1.
Texto completoRigolet, Muriel, Cyrielle Hou, Yasmine Baba Amer, Jessie Aouizerate, Baptiste Periou, Romain K. Gherardi, Peggy Lafuste y François Jérôme Authier. "Distinct interferon signatures stratify inflammatory and dysimmune myopathies". RMD Open 5, n.º 1 (febrero de 2019): e000811. http://dx.doi.org/10.1136/rmdopen-2018-000811.
Texto completoCarrero, Javier, Boris Calderon, Stephen Ferris y Emil Unanue. "Evaluation of the role of type I interferon to the development of type 1 diabetes. (BA3P.131)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 44.1. http://dx.doi.org/10.4049/jimmunol.192.supp.44.1.
Texto completoAn, Yuanyuan y Hua Duan. "The Comprehensive Analysis of Interferon-Related Prognostic Signature with regard to Immune Features in Ovarian Cancer". Disease Markers 2022 (20 de junio de 2022): 1–24. http://dx.doi.org/10.1155/2022/7900785.
Texto completoGallay, Laure, Guy Mouchiroud y Bénédicte Chazaud. "Interferon-signature in idiopathic inflammatory myopathies". Current Opinion in Rheumatology 31, n.º 6 (noviembre de 2019): 634–42. http://dx.doi.org/10.1097/bor.0000000000000653.
Texto completoRönnblom, Lars y Maija-Leena Eloranta. "The interferon signature in autoimmune diseases". Current Opinion in Rheumatology 25, n.º 2 (marzo de 2013): 248–53. http://dx.doi.org/10.1097/bor.0b013e32835c7e32.
Texto completoVieira, Matheus, Paul Régnier, Anna Maciejewski-Duval, Alexandre Le Joncour, Guillaume Darasse-Jèze, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub y David Saadoun. "Interferon signature in giant cell arteritis aortitis". Journal of Autoimmunity 127 (febrero de 2022): 102796. http://dx.doi.org/10.1016/j.jaut.2022.102796.
Texto completoGruber, Conor. "Impaired interferon signature in severe COVID-19". Nature Reviews Immunology 20, n.º 6 (30 de abril de 2020): 353. http://dx.doi.org/10.1038/s41577-020-0335-0.
Texto completoMagro, R., C. Saliba, L. Camilleri, C. Scerri y A. Borg. "THU0235 VITAMIN D AND INTERFERON SIGNATURE GENE EXPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 344.3–345. http://dx.doi.org/10.1136/annrheumdis-2020-eular.934.
Texto completoWigston, Z., A. Burska, A. Alase, K. Mahmoud y E. Vital. "OP0091 A TWO-SCORE INTERFERON SIGNATURE AND MUSCULOSKELETAL IMAGING EXPLAIN THE ASSOCIATION BETWEEN INTERFERON AND ARTHRITIS IN SLE". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 60.2–60. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3564.
Texto completoWu, Kang, Hai Fang, Liang-Dong Lyu, Douglas B. Lowrie, Ka-Wing Wong y Xiao-Yong Fan. "A Derived Network-Based Interferon-Related Signature of Human Macrophages Responding toMycobacterium tuberculosis". BioMed Research International 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/713071.
Texto completoTempleton, Amanda K., N. Dominguez, R. Lu, G. Vidal, J. Levin, A. Sestak, J. Kelly et al. "IRF5 Genetic Risk Haplotype Influences Host B Cell Gene Responses to Epstein-Barr Virus (EBV) (49.14)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 49.14. http://dx.doi.org/10.4049/jimmunol.182.supp.49.14.
Texto completoSadanandam, Anguraj, Pawan Poudel, Elisa Fontana y Chanthirika Ragulan. "Characterizing heterogeneity in KRAS mutant colorectal cancers (CRC) using cellular, mutation, and immune profiles." Journal of Clinical Oncology 36, n.º 4_suppl (1 de febrero de 2018): 657. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.657.
Texto completoWigston, Z., A. Burska, M. Wittmann y E. Vital. "POS0179 EXPLORING THE EFFECTS OF A TWO-SCORE INTERFERON SIGNATURE AND RESPONSES TO INTERFERON STIMULUS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 302.1–303. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1100.
Texto completoKomura, Kazuhiro, Yuki Ichimura, Naoko Okiyama, Kazuyoshi Watanabe, Hiroaki Muramoto y Takashi Matsushita. "Interferon signature in cutaneous lesion of COVID toes". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 20.37. http://dx.doi.org/10.4049/jimmunol.206.supp.20.37.
Texto completoObermoser, G. y V. Pascual. "The interferon-α signature of systemic lupus erythematosus". Lupus 19, n.º 9 (agosto de 2010): 1012–19. http://dx.doi.org/10.1177/0961203310371161.
Texto completoGuthridge, Joel M., Daniel N. Clark, Amanda Templeton, Nicolas Dominguez, Rufei Lu, Gabriel S. Vidal, Jennifer A. Kelly et al. "Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions". Journal of Biomedicine and Biotechnology 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/594056.
Texto completoGallucci, Stefania, Heather Bennett, Debra Shivers, Yue Ning, Edward Behrens, Neelakshi Jog, Roberto Caricchio y Uma Sriram. "Intrinsic Interferon Signature in Dendritic Cells in lupus-prone mice. (83.9)". Journal of Immunology 184, n.º 1_Supplement (1 de abril de 2010): 83.9. http://dx.doi.org/10.4049/jimmunol.184.supp.83.9.
Texto completoWu, Kang, Ka-Wing Wong, Wang-Long Deng, Hao Zhang, Jing Li, Douglas B. Lowrie y Xiao-Yong Fan. "The Numerical Predominance and Large Transcriptome Differences of Neutrophils in Peripheral Blood Together Inevitably Account for a Reported Pulmonary Tuberculosis Signature". International Journal of Genomics 2017 (2017): 1–8. http://dx.doi.org/10.1155/2017/5830971.
Texto completoRaupov, R., E. Suspitsin, R. Mulkidzhan y M. Kostik. "POS1312 ANALYSIS OF INTERFERON TYPE I SIGNATURE IN JUVENILE DERMATOMYOSITIS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 993.3–994. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3292.
Texto completoGenova, Elena, Maura Apollonio, Giuliana Decorti, Alessandra Tesser, Alberto Tommasini y Gabriele Stocco. "In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers". Molecules 26, n.º 12 (12 de junio de 2021): 3602. http://dx.doi.org/10.3390/molecules26123602.
Texto completoEdgar, Contessa, Deirdra Terrell, Sara Vesely, Igor Dozmorov, Jonathoan Wren, Mark Frank, Joan Merrill et al. "Immune and ribosomal gene expression associate with relapse in ADAMTS13-deficient thrombotic thrombocytopenic purpura (P4086)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 51.9. http://dx.doi.org/10.4049/jimmunol.190.supp.51.9.
Texto completoShamitova, E. N., M. A. Dubinkina y E. R. Khamidullova. "INTERFERON I SIGNATURE FOR DIFFERENTIAL DIAGNOSIS OF DISEASESOFTHE IMMUNESYSTEM". Научное обозрение. Биологические науки (Scientific Review. Biological Sciences), n.º 2 2022 (2022): 48–53. http://dx.doi.org/10.17513/srbs.1272.
Texto completoHaupl, T., R. Biesen, B. Smiljanovic, J. R. Grun, J. Weix, B. Stuhlmuller, P. M. Villiger, G. R. Burmester, A. Radbruch y A. Grutzkau. "The type 1 interferon signature: facts, fads and fallacies". Annals of the Rheumatic Diseases 70, Suppl 2 (22 de febrero de 2011): A24. http://dx.doi.org/10.1136/ard.2010.148965.26.
Texto completoFarias Amorim, Camila, Fernanda O. Novais, Ba T. Nguyen, Mauricio T. Nascimento, Jamile Lago, Alexsandro S. Lago, Lucas P. Carvalho, Daniel P. Beiting y Phillip Scott. "Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature". PLOS Neglected Tropical Diseases 15, n.º 4 (1 de abril de 2021): e0009321. http://dx.doi.org/10.1371/journal.pntd.0009321.
Texto completoHeimes, Anne-Sophie, Franziska Härtner, Katrin Almstedt, Slavomir Krajnak, Antje Lebrecht, Marco J. Battista, Karolina Edlund et al. "Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes". International Journal of Molecular Sciences 21, n.º 19 (29 de septiembre de 2020): 7178. http://dx.doi.org/10.3390/ijms21197178.
Texto completoKuo, Hung-Yang, Jhe-Cyuan Guo, Chia-Lang Hsu, Ta-Chen Huang y Chih-Hung Hsu. "The immunogenomic difference between Asian and non-Asian esophageal squamous cell carcinoma (ESCC) patients: An analysis of the Cancer Genome Atlas (TCGA) cohort." Journal of Clinical Oncology 38, n.º 5_suppl (10 de febrero de 2020): 27. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.27.
Texto completoWu, Zhicheng, Qiu Wang, Xiuqing Liu, Jiantong Zheng, Ling Ji y Xiaofeng Li. "Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma". Journal of Oncology 2022 (15 de octubre de 2022): 1–13. http://dx.doi.org/10.1155/2022/8998493.
Texto completoKossenkov, Andrew V., Andrew Milcarek, Faiyaz Notta, Gun-Ho Jang, Julie M. Wilson, Steven Gallinger, Daniel Cui Zhou et al. "Mitochondrial fitness and cancer risk". PLOS ONE 17, n.º 10 (12 de octubre de 2022): e0273520. http://dx.doi.org/10.1371/journal.pone.0273520.
Texto completoKostik, M., R. Raupov, R. Mulkidzhan, A. Kosmin y E. Suspitsin. "AB0001 INTERFERON SIGNATURE IN CHILDREN WITH CHRONIC NON-BACTERIAL OSTEOMYELITIS AND IT’S DYNAMIC AFTER BISPHOSPHONATES TREATMENT". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 1036.2–1036. http://dx.doi.org/10.1136/annrheumdis-2021-eular.508.
Texto completoRadke, Josefine, Randi Koll, Corinna Preuße, Debora Pehl, Kremena Todorova, Constanze Schönemann, Yves Allenbach et al. "Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis". Neurology - Neuroimmunology Neuroinflammation 5, n.º 3 (6 de marzo de 2018): e451. http://dx.doi.org/10.1212/nxi.0000000000000451.
Texto completoRaupov, R., E. Suspitsin, E. Kalashnikova, N. Lybimova, E. Kuchinskaya, R. Mulkidzhan, A. Kosmin y M. Kostik. "POS0078 CROSS-SECTIONAL ANALYSIS OF INTERFERON SIGNATURE IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 246.1–247. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1956.
Texto completoGallucci, Stefania, Linda Varghese, Heather Bennett, Neelakshi Jog, Debra Shivers, Yue Ning, Edward Behrens, Roberto Caricchio y Uma Sriram. "Intrinsic interferon signature in myeloid dendritic cells from lupus-prone mice precedes disease onset (47.1)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 47.1. http://dx.doi.org/10.4049/jimmunol.186.supp.47.1.
Texto completoAvdeeva, A. S., E. V. Tchetina, M. V. Cherkasova, G. A. Markova, A. S. Artyuhov, E. B. Dashinimaev y E. L. Nasonov. "The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)". Rheumatology Science and Practice 58, n.º 6 (14 de enero de 2021): 673–77. http://dx.doi.org/10.47360/1995-4484-2020-673-677.
Texto completoKhan, Sabbir, Rajasekaran Mahalingam, Shayak Sen, Kaitlin Gandy, Kristin Alfaro-Munoz, Nazanin Majd, Veerakumar Balasubramaniyan y John DeGroot. "STEM-24. INTERFERON SIGNALING REGULATES THE PROLIFERATION AND MESENCHYMAL PHENOTYPE OF GLIOBLASTOMA STEM CELLS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi26. http://dx.doi.org/10.1093/neuonc/noab196.098.
Texto completoGillezeau, Christina, Naimisha Movva, Maaike van Gerwen, Karma Rabon-Stith, Norah Shire, Philip Zachary Brohawn, Emanuela Taioli y Jon Fryzek. "Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients". PLOS ONE 17, n.º 8 (30 de agosto de 2022): e0271339. http://dx.doi.org/10.1371/journal.pone.0271339.
Texto completoMattson, Lina, Antonio Lentini, Danuta R. Gawel, Tejaswi V. S. Badam, Mikael Benson, Torbjorn Ledin, Colm E. Nestor et al. "Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis". Journal of Immunology Research 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/5153184.
Texto completoTsao, Y. P., F. Y. Tseng, C. W. Chao, M. H. Chen y S. T. Chen. "OP0045 NLRP12 INVOLVES IN THE LUPUS WITH POSITIVE INTERFERON SIGNATURE". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 23.2–24. http://dx.doi.org/10.1136/annrheumdis-2021-eular.4215.
Texto completoTong, Run, Lin Feng, Lei Zhang, Jianzhi Zhang, Yousheng Mao, Kaitai Zhang, Yanning Gao, Guiqi Wang y Shujun Cheng. "Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis". Journal of Interferon & Cytokine Research 35, n.º 12 (diciembre de 2015): 963–68. http://dx.doi.org/10.1089/jir.2015.0061.
Texto completoBienkowska, Jadwiga, Norm Allaire, Alice Thai, Jaya Goyal, Tatiana Plavina, Ajay Nirula, Megan Weaver et al. "Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis". PLoS ONE 9, n.º 11 (18 de noviembre de 2014): e112545. http://dx.doi.org/10.1371/journal.pone.0112545.
Texto completoUruha, A., Y. Allenbach, J. Charuel, L. Musset, A. Aussy, O. Boyer, K. Mariampillai et al. "Type 1 interferon signature as a diagnostic marker of dermatomyositis". Neuromuscular Disorders 27 (octubre de 2017): S152—S153. http://dx.doi.org/10.1016/j.nmd.2017.06.216.
Texto completoUruha, A., Y. Allenbach, J. L. Charuel, L. Musset, A. Aussy, O. Boyer, K. Mariampillai et al. "Type 1 interferon signature as a diagnostic marker of dermatomyositis". Journal of the Neurological Sciences 381 (octubre de 2017): 1082. http://dx.doi.org/10.1016/j.jns.2017.08.3053.
Texto completoKamiyama, Reikou, Ryusuke Yoshimi, Mitsuhiro Takeno, Yasuhiro Iribe, Toshinori Tsukahara, Daiga Kishimoto, Yosuke Kunishita et al. "Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus". Modern Rheumatology 28, n.º 6 (23 de febrero de 2018): 993–1003. http://dx.doi.org/10.1080/14397595.2018.1436028.
Texto completoNocturne, Gaetane y Xavier Mariette. "Interferon signature in systemic autoimmune diseases: what does it mean?" RMD Open 8, n.º 2 (diciembre de 2022): e002687. http://dx.doi.org/10.1136/rmdopen-2022-002687.
Texto completoBuie, Joy y James Oates. "Interferon alpha deregulates endothelial nitric oxide synthase (P4085)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 127.14. http://dx.doi.org/10.4049/jimmunol.190.supp.127.14.
Texto completoHaberman Ziv, Y., N. Loberman-Nachum, S. Katya, A. Di Segni, G. Efroni, T. Braun, M. BenShoshan et al. "OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis". Journal of Crohn's and Colitis 14, Supplement_1 (enero de 2020): S006. http://dx.doi.org/10.1093/ecco-jcc/jjz203.005.
Texto completoHuard, C., S. V. Gullà, D. V. Bennett, A. J. Coyle, R. A. Vleugels y S. A. Greenberg. "Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis". British Journal of Dermatology 176, n.º 5 (14 de marzo de 2017): 1224–30. http://dx.doi.org/10.1111/bjd.15006.
Texto completoAvdeeva, A., E. Tchetina, G. Markova y E. Nasonov. "POS0611 THE EFFECT OF RITUXIMAB BIOSIMILAR THERAPY ON THE EXPRESSION OF INTERFERON-STIMULATED GENES (“INTERFERON SIGNATURE”) IN PATIENTS WITH RHEUMATOID ARTHRITIS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 542.2–542. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1551.
Texto completo